Conclusions
LMs
SECONDARY, LIVER METASTASES, COLORECTAL CANCER
In this secondary analysis of the CCTG CO.26 trial, LMs were associated with worse survival outcomes among patients with advanced colorectal cancer. Liver metastases should be considered in the design and interpretation of future clinical studies evaluating ICI therapy.